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Abstract
Introduction: Osteoarthritis (OA) is the most common bone and joint disease influenced by genetic and
environmental factors. Recent association studies have uncovered the genetic factors behind OA, its susceptibility
genes, which would enable us to predict disease occurrence based on genotype information. However, most
previous studies have evaluated the effects of only a single susceptibility gene, and hence prediction based on
such information is not as reliable. Here, we constructed OA-prediction models based on genotype information
from a case-control association study and tested their predictability.
Methods: We genotyped risk alleles of the three susceptibility genes, asporin (ASPN), growth differentiation factor
5( GDF5), and double von Willebrand factor A domains (DVWA) for a total of 2,158 Japanese subjects (933 OA and
1,225 controls) and statistically analyzed their effects. After that, we constructed prediction models by using the
logistic regression analysis.
Results: When the effects of each allele were assumed to be the same and multiplicative, each additional risk
allele increased the odds ratio (OR) by a factor of 1.23 (95% confidence interval (CI), 1.12 to 1.34). Individuals with
five or six risk alleles showed significantly higher susceptibility when compared with those with zero or one, with
an OR of 2.67 (95% CI, 1.46 to 4.87; P = 0.0020). Statistical evaluation of the prediction power of models showed
that a model using only genotyping data had poor predictability. We obtained a model with good predictability
by incorporating clinical data, which was further improved by rigorous age adjustment.
Conclusions: Our results showed that consideration of adjusted clinical information, as well as increases in the
number of risk alleles to be integrated, is critical for OA prediction by using data from case-control studies. To the
authors’ knowledge, this is the first report of the OA-prediction model combining both genetic and clinical
information.
Introduction
Osteoarthritis (OA) is the most common bone and joint
disease and is characterized by progressive cartilage
degeneration. OA is a polygenic disease caused by
genetic and environmental factors [1]. Epidemiologic
studies have suggested that genetic factors strongly
affect the onset and development of OA [2]. Genetic
association studies are now uncovering the genetic fac-
tors responsible for of OA, that is, its susceptibility
genes. Candidate-gene approaches have identified sev-
eral genes associated with OA, and genome-wide
association studies have recently found several promis-
ing OA-susceptibility genes [1,3].
Identification of OA-susceptibility genes would enable
us to predict disease phenotypes based on genotype
information. Such predictions would be a basis for per-
sonalized medicine and disease prevention. However,
most previous OA genetic studies have evaluated the
effects of only single susceptibility genes, which are
mostly small, and hence predictions based on their
results are not always useful. By analyzing the combina-
torial effects of the gene calmodulin 1 (CALM1)a n d
other genes in hip OA susceptibility, combinatorial asso-
ciation between CALM1 and ASPN susceptibility alleles
has been reported [4]; however, the association was not
conclusive because of the small sample size of the study.
Because OA is a polygenic disease, evaluation of the
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between susceptibility genes and environmental/clinical
factors, is important.
To obtain a more-comprehensive view of knee OA
susceptibility and to make a good prediction model for
OA by using genotype information, we investigated the
combined effects of known susceptibility genes for knee
OA in Japanese persons. We examined gene-gene inter-
actions of the previously reported OA genes and esti-
mated the population attributed risk (PAR) statistic of
the genes by using data of a case-control association
study [5]. We constructed prediction models for OA by
using genetic data only and a combination of genetic
and clinical data, and evaluated their predictability sta-
tistically. The model using only genotype information
had less than fair predictability, but integration of clini-
cal data with adjustment showed marked improvement
of the prediction power.
Materials and methods
Subjects
A case-control cohort (692 cases and 748 controls) was
recruited from patients of several medical institutes in
Japan. A population-based cohort (241 cases and 477
controls) was recruited from inhabitants of Odai and
Minami-ise town in the Mie prefecture in Japan. We
obtained written informed consent from each subject,
and the study was approved by the ethics committee
of the Center for Genomic Medicine in RIKEN. In
total, 933 knee OA (81.1% female; mean age ± stan-
dard deviation (SD) = 71.8 ± 7.7 years) and 1,225 con-
trol subjects (75.4% female; mean age ± SD = 69.3 ±
9.2 years) were included. OA was diagnosed based on
clinical and radiographic findings by using previously
described criteria [6]. All OA patients were older than
40 years.
Genotyping
DNA was extracted from peripheral blood by using
standard methods. ASPN D-repeat polymorphism [7],
rs143383 in GDF5 [8], and rs7639618 in DVWA [6]
were genotyped as described previously.
Statistical analysis
We used the software R [9] for all statistical analyses.
To obtain PAR for multiple risk factors among case-
control study data, we used an OR assessed by the logis-
tic regression model adjusted for gender and age [10].
Prediction model
We used logistic regression for constructing prediction
models. This method assumes a multiplicative allelic
effect (each allele independently increases the odds of
the disease). We used the Cochran-Armitage trend test
to examine this odds increase by increasing the number
of risk alleles. The variables of the logistic regression
model with clinical data remained after the stepwise
selection of variables based on the likelihood ratio and
the Wald statistics [11,12]. We used the receiver operat-
ing characteristic (ROC) curve to evaluate abilities of
prediction models. The area under the curve (AUC),
which is a measure of the power to distinguish case and
control individuals, was calculated for the curve by
using the ROCR package [13]. The simulation study for
the adjusted control group was performed 1,000 times.
A perfect model would have an AUC of 1, whereas a
model with no discriminative power would have an
AUC of 0.5 [14].
Estimation of contribution of the genetic factor
We considered a statistical model for prediction as fol-
lows:
Phenotype Genotype Clinical  factor  PG E () = () + () .
By taking variances on the liability scale for both sides
of equation, this model becomes:
Var P Var G Var E Cov G E () = () + () + () , .
As we found no evidence of gene-environmental
interactions, we could assume that Cov(G,E)=0 .W e
also estimated the contribution of genetic factors in
our models by calculating the average proportion of
variation, Var(E)/Var(P), for 1,000 simulation
studies.
Results
Selection of susceptibility genes
We selected three susceptibility genes, ASPN [7], GDF5
[8], and DVWA [6], for study because they had clear
associations in Japanese subjects and because the asso-
ciations were replicated in other ethnic populations and
supported by functional evidence for OA causality [1,3].
We obtained clinical data (Table 1) and genotyping data
(Table 2) for 933 knee OA cases and 1,225 controls and
examined whether the previously reported risk alleles
Table 1 Clinical data of subjects
Variable Case Control
Female Male Female Male
Number (% of subjects) 757 (81.1) 176 (18.9) 924 (75.4) 301 (24.6)
Age, years (SD) 71.6 (7.5) 72.9 (8.7) 70.3 (8.7) 66.2 (10.2)
Height, cm (SD) 150.2 (6.1) 161.5 (6.8) 149.9 (6.1) 162.9 (7.5)
Weight, kg (SD) 56.2 (8.9) 63.8 (11.1) 51.5 (9.0) 63.8 (10.7)
BMI, kg/m
2 (SD) 24.9 (12.7) 24.4 (11.0) 22.9 (12.1) 23.9 (8.75)
Only subjects successfully genotyped for all polymorphisms are included. SD,
standard deviation.
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genotyping. We observed significant associations in
GDF5 and DVWA and marginal associations in ASPN
(Table 3).
Association between number of risk alleles and knee OA
We tested the independence between risk alleles for all
pair-wise combinations by a c
2 association test to 3 × 3
tables by using both case-only and case-control mixed
designs. We did not find evidence of dependence. We
next examined gene-gene interactions by using the logis-
tic regression model. We considered analysis of variance
between two logistic regression models, with or without
the term of gene-gene interaction. After Bonferroni
correction (P = 0.05/3 for three pair-wise combinations
among three genes), we did not find any evidence of
interaction (Table 4).
We then studied the association between knee OA
and the number of risk alleles possessed by a subject
(Table 5). The distributions of the subjects over the
number of risk alleles differed between the case and
control groups. The odds ratio adjusted for age, gen-
der, and body mass index (BMI) increased with the
number of risk alleles (Figure 1) (P = 4.15e-6). As only
0.7% of subjects in the control group carried zero risk
alleles, we selected subjects with either zero or one
risk allele as a reference (the lowest-risk) group. The
proportion of the group was 10.6%. Similarly, we com-
bined subjects with five or six risk alleles to construct
the highest-risk group. The group had an OR of 2.67
( 9 5 %C I ,1 . 4 6t o4 . 8 7 ;P = 0.0020), as compared with
the reference group.
Estimation of PAR
To investigate the contribution of genetic factors for
the onset OA, we estimated the PAR statistic [5]. PAR
is the proportion of cases in the population that can
avoid the disease if certain risk alleles are removed
from the population. Hence, PAR is useful for provid-
ing a measure of how much a certain factor contri-
butes to the disease. We compared the reference group
with other groups and obtained an estimated PAR of
31.4% for the risk alleles of the three susceptibility
genes. We also considered PAR for BMI because the
Framingham study indicated that a higher BMI may
increase the OA risk [2]. We classified BMIs for all
subjects into three categories (normal/underweight,
<25; overweight, 26 to 30, and obese, ≥30) [15]. Setting
normal/underweight as a reference group, we esti-
mated the PAR of BMI as 28.4%.
Application for prediction of OA susceptibility
We generated OA-prediction models by using genetic
or clinical data or both. We first examined the inter-
actions between genetic and clinical factors and found
no evidence of interactions, or of gene-gene interac-
tions. We next considered two logistic regression
models: the first model (MODEL I) was constructed
with only the number of risk alleles for the three sus-
ceptibility genes; the second model (MODEL II) incor-
porated the clinical information of individuals,
including gender, age, and BMI. For both models, we
confirmed that each additional risk allele increased
ORs by 1.23 (95%CI, 1.12 to 1.34) and 1.22 (95%CI,
1.11 to 1.34), respectively. For MODEL II, the contri-
butions of gender, age, and BMI were 1.35 for female,
Table 2 Genotyping data of subjects
Gene Genotype count
a Risk-allele frequency
Homo Hetero Others
ASPN Case 9 127 797 0.078
Control 3 147 1,075 0.062
GDF5 Case 566 313 54 0.774
Control 684 461 80 0.747
DVWA Case 369 428 136 0.625
Control 397 600 228 0.569
aFor the risk allele. ASPN, aspirin; DVWA, double von Willebrand factor A
domain; GDF5, growth differentiation factor 5.
Table 3 Association between three genes and knee OA
Gene Odds ratio 95% CI P value
a
ASPN 1.26 1.00 to 1.60 0.058
GDF5 1.17 1.01 to 1.34 0.037
DVWA 1.26 1.12 to 1.43 0.0024
aP values based on c
2 association test to 2 × 2 tables by allele model for
GDF5 and DVWA, and by D14 versus others for ASPN. ASPN, aspirin; CI,
confidence interval; DVWA, double von Willebrand factor A domain; GDF5,
growth differentiation factor 5.
Table 4 Test of independence and gene-gene interactions
Interaction P value
Case-control
a Case-only
b Two models
c
ASPN × GDF5 0.598 0.273 0.056
GDF5 × DVWA 0.416 0.701 0.920
DVWA × ASPN 0.197 0.104 0.290
a, bP values based on c
2 association test to 3 × 3 tables by genotype model.
cANOVA for two logistic regression models, with or without interactions.
ASPN, aspirin; DVWA, double von Willebrand factor A domain; GDF5, growth
differentiation factor 5.
Table 5 Number of risk alleles possessed by subjects
Allele 0 1 2 3 4 5 6
Case 6 61 224 357 252 30 3
Control 9 121 332 485 254 24 0
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respectively.
By a logit transformation, the probability induced by
MODEL I is expressed as:
P
n
n
=
+×
++ ×
exp( . . )
exp( . . )
0 856 0 205
1 0 856 0 205
where n is the number of risk alleles.
In MODEL II, the probability is expressed with clini-
cal data of the subjects as:
P
n gen age BMI
=
−+× +× +× +×
+−
exp( . . . . . )
exp(
8 395 0 200 0 302 0 045 0 162
1 8 8 395 0 200 0 302 0 045 0 162 .. . . . ) +× +× +× +× n gen age BMI
where the value of gen is 1 or 2 if the subject is male
or female, respectively. We drew an ROC curve and
evaluated the predictive power of the model by AUC
[16]. AUCs of MODEL I and MODEL II were 0.554 and
0.685, respectively (Figure 2).
To examine the contribution of clinical factors, we
constructed a model by using only clinical data
(MODEL III). We obtained an AUC of 0.678, which was
very similar to that of MODEL II; however, comparison
between MODEL II and MODEL III by a likelihood
r a t i ot e s ts h o w e das i g n i f i c a n td i f f e r e n c e( P = 1.67e-5),
indicating that MODEL II was superior to MODEL III.
To examine the validity of the prediction model, we
did a validation study as follows: We divided our sub-
jects into two sets, the cohort study (718 subjects) and
the others (1,440 subjects). By using data of the latter
set, we constructed MODEL II and applied the model to
the data of the former set. Consequently, we obtained
an AUC of 0.717 for the validation study, whereas the
AUC for the original study was 0.649.
Adjustment of clinical data for the control group
A prediction model is generally interpreted to be excel-
lent, good, or fair, when its AUC is 0.9 to 1.0, 0.8 to 0.9,
or 0.7 to 0.8, respectively [17]. Therefore, our models
were poor. This was partly because the proportion of
male subjects in our control group was only 0.246,
which does not reflect that of the general Japanese
population. Hence, we adjusted the age by selecting sub-
jects from the case and control groups whose ages were
60 years or older for constructing MODEL II. Mean
ages ± SD (years) of the case and control groups were
73.2 ± 6.2 and 72.0 ± 6.8, respectively. We then con-
structed a control group with random sampling for 171
male and 215 female sunjects, which was the same
male-to-female ratio as that in the Japanese population
in 2005. We also selected 400 case subjects at random
and applied the logistic regression model to them.
Figure 1 Odds ratios for subjects with different numbers of risk
alleles for knee OA. Effects of the number of ASPN, GDF5,a n dDVWA
susceptibility risk alleles on knee osteoarthritis (OA) risk. Odds ratios
(ORs) and their 95% confidence intervals according to the number of
risk alleles were calculated by using a logistic regression model
adjusted for gender, age, and body mass index. We set the control
group as subjects who have zero or one risk allele. Each additional risk
allele increased the OR by 1.22 (95% CI, 1.11 to 1.34), which indicated
the cumulative effects of the three alleles on knee OA.
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Figure 2 ROC (receiver operating characteristic) curves of two
prediction models. ROC curves of prediction models that used
only genetic factors (MODEL I, AUC = 0.554) and that used both
genetic factors and clinical data with age adjustment in the
selected control group (MODEL II, AUC = 0.742). The curve for
MODEL II was drawn through 1,000 simulation studies with rigorous
age adjustment for control groups that reflected the Japanese
elderly population. MODEL II had a significantly improved AUC.
Curves were described by using the ROCR package.
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AUC of 0.867.
The distribution of subject ages in our control group
was slightly different from that of the general Japanese
population. Thus, we selected 128 male and 163 female
sunjects so that the subjects in the control group had an
equivalent age distribution to the Japanese population in
2005. We then applied the logistic regression model to
291 randomly selected cases. The simulation studies
showed a mean AUC of 0.742 for MODEL II (Figure 2).
For the model, we estimated the contribution of genetic
factors by calculating the proportion of variation and
f o u n di tv e r yl o w( 0 . 0 6 0 ) ,w h ich indicated a nonsignifi-
cant contribution of the genetic factor in the model.
Actually, we obtained a mean AUC of 0.735 for
MODEL III. To confirm the prediction models, we also
performed cross-validation studies and obtained their
AUCs as 0.677 and 0.671, respectively, which were not
different from the original ones.
Our case subjects mainly consisted of women (81.1%),
and epidemiology studies have reported that women
h a v eah i g h e rr i s ko fO At h a nd om e n[ 2 ] .H e n c e ,w e
also applied our models to only male or female subjects.
With age adjustment for control subjects, we used 128
cases and 128 controls for men, and 462 cases and 462
controls for women. For men and women, we obtained
AUCs of 0.737 and 0.696, respectively, and estimated
the contribution of the genetic factor to be 0.110 and
0.091, respectively. The increasing proportions of
genetic factors in these models were attributed to the
fact that they did not contain gender information.
Discussion
Classic twin studies on OA heritability suggested that
more than half of variations related to the OA suscept-
ibility can be explained by genetic factors [18]. There-
fore, we first tested a model that considered genotype
information only. The prediction model had a low pre-
dictability; its AUC was only 0.554. The insufficient
power of the model was partly due to the small number
of integrated risk alleles. It has been reported that 20 to
25 risk alleles with frequencies greater than 0.1 and OR
values of 1.5 are required for obtaining an AUC of
about 0.8 [19]. A precedent study presented a similar
model to our MODEL I and reported the additive effect
of candidate genes associated with OA [20].
Based on our PAR analysis, the contributions of
genetic factors for OA composed by three risk alleles
was similar to that of the BMI (31.4% versus 28.4%).
The proportion of variations and estimated contribu-
tions of genetic factors for our prediction model was
calculated to be very low when compared with the pre-
vious twin studies [18]. Finding additional risk variants
and integrating them into the model is necessary to
increase the power of the model.
To improve the predictability of the model, we inte-
grated clinical information, which increased the AUC to
0.685. We further modified the model by adjusting the
age because our control group was composed of older
subjects, as compared with the case group. After this
adjustment, the AUC increased to 0.742. The effect of
age difference between the case and control groups was
confirmed by simulating the control group and a ran-
dom sampling that considered only the male-to-female
ratio and selected case subjects under the same condi-
tions. The applied logistic regression model produced an
AUC of 0.867. These results showed that despite slight
differences in age between the case and control groups,
mean values could be inflated. Thus, the distribution of
age in the control group was influential for constructing
a prediction model, underscoring the importance of age
adjustment for the control group.
Among the three susceptibility genes, we found no
evidence of interaction. We also found no evidence of
interaction between the four clinical factors. We are
uncertain whether the lack of interaction is true for only
the factors that we examined, but it may be due to the
limitations in the power of our study resulting from the
sample size. It was previously shown that GDF5 may
contribute to the variation in height with an estimated
additive effect [21]; however, we did not find such an
association in our study. Both gene-gene and gene-
environment interactions should play roles in common
diseases, and we may therefore be able to increase the
predictive power by finding the yet-unidentified variants
that interact with clinical-environmental factors.
Our prediction model for knee OA was constructed
based on data from a case-control association study. In
type 2 diabetes, some prediction models have been con-
sidered based on case-control study data that have
incorporated the number of risk alleles and clinical data
[17,22,23]. These approaches have achieved successful
outcomes; however, unlike a cohort study, data from
control subjects may not reflect the true distribution of
ages for the target population. In the case in which sus-
ceptibility to disease varies with age, it is necessary to
consider the age distribution among the control group.
To our knowledge, our approach with adjustment of
clinical information is the first to construct prediction
models using case-control studies, while considering this
problem. Our approach can compare prediction models
induced by genetic data, clinical data, and both of them
and can estimate the contribution of genetic factors for
the last model. It would be useful in future preventive
measures against not only OA, but also other common
polygenic diseases.
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To our knowledge, this study is the first report of an
OA-prediction model combining with genetic and clini-
cal information from a case-control association study.
Our prediction model using genotype information from
three susceptibility genes had poor predictability; how-
ever, predictability improved significantly by incorporat-
ing clinical data and by adjusting those data. In the
current model, the contribution of genetic factors is
small. The identification of more OA-risk polymorph-
isms is necessary; these should be integrated to achieve
better prediction.
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